fbpx
September 15, 2023

Reassuring Real-World Data on Redo TAVR Reassuring Real-World Data on Redo TAVR

Repeat transcatheter aortic valve replacement (TAVR) with a balloon-expandable valve is effective in treating a failed first transcatheter valve, with low procedural risks and with clinical […]
September 15, 2023

Sotatercept Tied to Disease Modification in PAH Sotatercept Tied to Disease Modification in PAH

MILAN — Sotatercept, a first-in-class activin signaling inhibitor, is currently under scrutiny as a potential game-changer in the treatment of pulmonary arterial hypertension (PAH). Data unveiled […]
September 15, 2023

Antigen Tests: After Pandemic Success, Time for Bigger Role? Antigen Tests: After Pandemic Success, Time for Bigger Role?

Before the pandemic, most of the public probably had a fleeting and limited familiarity with lateral flow tests (LFTs), also known as rapid antigen tests. Perhaps […]
September 15, 2023

New Antibiotic Could Combat Multidrug-Resistant Superbugs New Antibiotic Could Combat Multidrug-Resistant Superbugs

Antibiotic resistance is a major public health problem. Few new molecules are in development, but a new antibiotic called clovibactin brings hope. This drug, isolated from […]
September 15, 2023

Lupus May Overlap in Many Patients With Systemic Sclerosis Lupus May Overlap in Many Patients With Systemic Sclerosis

TOPLINE: Patients with both systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) are more likely to be female, Black, and diagnosed with limited cutaneous SSc. METHODOLOGY: […]
September 15, 2023

Does Your Menopause Care Meet Your Patients’ Needs? Does Your Menopause Care Meet Your Patients’ Needs?

In 2017, a survey of 20 U.S. residency programs in family medicine, internal medicine, and ob.gyn. showed that only 6.8% of residents felt they were being […]
September 15, 2023

It’s Back to School for Asthma, Too It’s Back to School for Asthma, Too

PARIS — The years go by, and nothing much changes: the first 2 weeks of the new school year have brought with them a rise in […]
September 15, 2023

Should NSCLC Patients Receive Immunotherapy ‘Indefinitely’? Should NSCLC Patients Receive Immunotherapy ‘Indefinitely’?

Most patients with non–small cell lung cancer (NSCLC) who are long-term responders to immunotherapy will continue receiving treatment beyond 2 years. However, the best available evidence […]
September 14, 2023

PCPs Prep for ‘Less Predictable’ Respiratory Virus Season PCPs Prep for ‘Less Predictable’ Respiratory Virus Season

Hospitalizations for COVID-19 in the United States have increased for 8 weeks in a row. Data from Florida and Georgia signal that respiratory syncytial virus (RSV) […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674675676677678679680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731732733734735736737738739740741742743744745746747748749750751752753754755756757758759760761762763764765766767768769770771772773774775776777778779780781782783784785786787788789790791792793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860861862863864865866867868869870871872873874875876877878879880881882883884885886887888889890891892893894895896897898899900901902903904905906907908909910911912913914915916917918919920921922923924925926927928929930931932933934935936937938939940941942943944945946947948949950951952953954955956957958959960961962963964965966967968969970971972973974975976977
Next page
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0